Generic Drug-Global Market Status and Trend Report 2013-2023
Report Summary
Generic Drug-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Generic Drug industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Generic Drug 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Generic Drug worldwide, with company and product introduction, position in the Generic Drug market
Market status and development trend of Generic Drug by types and applications
Cost and profit status of Generic Drug, and marketing status
Market growth drivers and challenges
The report segments the global Generic Drug market as:
Global Generic Drug Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Generic Drug Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Pure (Non-branded) Generics
Branded Generics
Super Generics
Global Generic Drug Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Cardiovascular & Hypertension
Dermatology
Diabetes
Rheumatology
Oncology
Gastrointestinal
Others
Global Generic Drug Market: Manufacturers Segment Analysis (Company and Product introduction, Generic Drug Sales Volume, Revenue, Price and Gross Margin):
Teva Pharma.
Novartis company
Mylan
Allergan
Hospira
Dr. Reddy?s Lab.
Stada
Greenstone
Par Pharma
Sun Pharmaceutical
Aspen Pharmacare
Fresenius
Lupin
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Generic Drug-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Generic Drug industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Generic Drug 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Generic Drug worldwide, with company and product introduction, position in the Generic Drug market
Market status and development trend of Generic Drug by types and applications
Cost and profit status of Generic Drug, and marketing status
Market growth drivers and challenges
The report segments the global Generic Drug market as:
Global Generic Drug Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Generic Drug Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Pure (Non-branded) Generics
Branded Generics
Super Generics
Global Generic Drug Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Cardiovascular & Hypertension
Dermatology
Diabetes
Rheumatology
Oncology
Gastrointestinal
Others
Global Generic Drug Market: Manufacturers Segment Analysis (Company and Product introduction, Generic Drug Sales Volume, Revenue, Price and Gross Margin):
Teva Pharma.
Novartis company
Mylan
Allergan
Hospira
Dr. Reddy?s Lab.
Stada
Greenstone
Par Pharma
Sun Pharmaceutical
Aspen Pharmacare
Fresenius
Lupin
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF GENERIC DRUG
1.1 Definition of Generic Drug in This Report
1.2 Commercial Types of Generic Drug
1.2.1 Pure (Non-branded) Generics
1.2.2 Branded Generics
1.2.3 Super Generics
1.3 Downstream Application of Generic Drug
1.3.1 Cardiovascular & Hypertension
1.3.2 Dermatology
1.3.3 Diabetes
1.3.4 Rheumatology
1.3.5 Oncology
1.3.6 Gastrointestinal
1.3.7 Others
1.4 Development History of Generic Drug
1.5 Market Status and Trend of Generic Drug 2013-2023
1.5.1 Global Generic Drug Market Status and Trend 2013-2023
1.5.2 Regional Generic Drug Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Generic Drug 2013-2017
2.2 Production Market of Generic Drug by Regions
2.2.1 Production Volume of Generic Drug by Regions
2.2.2 Production Value of Generic Drug by Regions
2.3 Demand Market of Generic Drug by Regions
2.4 Production and Demand Status of Generic Drug by Regions
2.4.1 Production and Demand Status of Generic Drug by Regions 2013-2017
2.4.2 Import and Export Status of Generic Drug by Regions 2013-2017
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Production Volume of Generic Drug by Types
3.2 Production Value of Generic Drug by Types
3.3 Market Forecast of Generic Drug by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Generic Drug by Downstream Industry
4.2 Market Forecast of Generic Drug by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF GENERIC DRUG
5.1 Global Economy Situation and Trend Overview
5.2 Generic Drug Downstream Industry Situation and Trend Overview
CHAPTER 6 GENERIC DRUG MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
6.1 Production Volume of Generic Drug by Major Manufacturers
6.2 Production Value of Generic Drug by Major Manufacturers
6.3 Basic Information of Generic Drug by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Generic Drug Major Manufacturer
6.3.2 Employees and Revenue Level of Generic Drug Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 GENERIC DRUG MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Teva Pharma.
7.1.1 Company profile
7.1.2 Representative Generic Drug Product
7.1.3 Generic Drug Sales, Revenue, Price and Gross Margin of Teva Pharma.
7.2 Novartis company
7.2.1 Company profile
7.2.2 Representative Generic Drug Product
7.2.3 Generic Drug Sales, Revenue, Price and Gross Margin of Novartis company
7.3 Mylan
7.3.1 Company profile
7.3.2 Representative Generic Drug Product
7.3.3 Generic Drug Sales, Revenue, Price and Gross Margin of Mylan
7.4 Allergan
7.4.1 Company profile
7.4.2 Representative Generic Drug Product
7.4.3 Generic Drug Sales, Revenue, Price and Gross Margin of Allergan
7.5 Hospira
7.5.1 Company profile
7.5.2 Representative Generic Drug Product
7.5.3 Generic Drug Sales, Revenue, Price and Gross Margin of Hospira
7.6 Dr. Reddy?s Lab.
7.6.1 Company profile
7.6.2 Representative Generic Drug Product
7.6.3 Generic Drug Sales, Revenue, Price and Gross Margin of Dr. Reddy?s Lab.
7.7 Stada
7.7.1 Company profile
7.7.2 Representative Generic Drug Product
7.7.3 Generic Drug Sales, Revenue, Price and Gross Margin of Stada
7.8 Greenstone
7.8.1 Company profile
7.8.2 Representative Generic Drug Product
7.8.3 Generic Drug Sales, Revenue, Price and Gross Margin of Greenstone
7.9 Par Pharma
7.9.1 Company profile
7.9.2 Representative Generic Drug Product
7.9.3 Generic Drug Sales, Revenue, Price and Gross Margin of Par Pharma
7.10 Sun Pharmaceutical
7.10.1 Company profile
7.10.2 Representative Generic Drug Product
7.10.3 Generic Drug Sales, Revenue, Price and Gross Margin of Sun Pharmaceutical
7.11 Aspen Pharmacare
7.11.1 Company profile
7.11.2 Representative Generic Drug Product
7.11.3 Generic Drug Sales, Revenue, Price and Gross Margin of Aspen Pharmacare
7.12 Fresenius
7.12.1 Company profile
7.12.2 Representative Generic Drug Product
7.12.3 Generic Drug Sales, Revenue, Price and Gross Margin of Fresenius
7.13 Lupin
7.13.1 Company profile
7.13.2 Representative Generic Drug Product
7.13.3 Generic Drug Sales, Revenue, Price and Gross Margin of Lupin
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF GENERIC DRUG
8.1 Industry Chain of Generic Drug
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF GENERIC DRUG
9.1 Cost Structure Analysis of Generic Drug
9.2 Raw Materials Cost Analysis of Generic Drug
9.3 Labor Cost Analysis of Generic Drug
9.4 Manufacturing Expenses Analysis of Generic Drug
CHAPTER 10 MARKETING STATUS ANALYSIS OF GENERIC DRUG
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Generic Drug in This Report
1.2 Commercial Types of Generic Drug
1.2.1 Pure (Non-branded) Generics
1.2.2 Branded Generics
1.2.3 Super Generics
1.3 Downstream Application of Generic Drug
1.3.1 Cardiovascular & Hypertension
1.3.2 Dermatology
1.3.3 Diabetes
1.3.4 Rheumatology
1.3.5 Oncology
1.3.6 Gastrointestinal
1.3.7 Others
1.4 Development History of Generic Drug
1.5 Market Status and Trend of Generic Drug 2013-2023
1.5.1 Global Generic Drug Market Status and Trend 2013-2023
1.5.2 Regional Generic Drug Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Generic Drug 2013-2017
2.2 Production Market of Generic Drug by Regions
2.2.1 Production Volume of Generic Drug by Regions
2.2.2 Production Value of Generic Drug by Regions
2.3 Demand Market of Generic Drug by Regions
2.4 Production and Demand Status of Generic Drug by Regions
2.4.1 Production and Demand Status of Generic Drug by Regions 2013-2017
2.4.2 Import and Export Status of Generic Drug by Regions 2013-2017
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Production Volume of Generic Drug by Types
3.2 Production Value of Generic Drug by Types
3.3 Market Forecast of Generic Drug by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Generic Drug by Downstream Industry
4.2 Market Forecast of Generic Drug by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF GENERIC DRUG
5.1 Global Economy Situation and Trend Overview
5.2 Generic Drug Downstream Industry Situation and Trend Overview
CHAPTER 6 GENERIC DRUG MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
6.1 Production Volume of Generic Drug by Major Manufacturers
6.2 Production Value of Generic Drug by Major Manufacturers
6.3 Basic Information of Generic Drug by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Generic Drug Major Manufacturer
6.3.2 Employees and Revenue Level of Generic Drug Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 GENERIC DRUG MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Teva Pharma.
7.1.1 Company profile
7.1.2 Representative Generic Drug Product
7.1.3 Generic Drug Sales, Revenue, Price and Gross Margin of Teva Pharma.
7.2 Novartis company
7.2.1 Company profile
7.2.2 Representative Generic Drug Product
7.2.3 Generic Drug Sales, Revenue, Price and Gross Margin of Novartis company
7.3 Mylan
7.3.1 Company profile
7.3.2 Representative Generic Drug Product
7.3.3 Generic Drug Sales, Revenue, Price and Gross Margin of Mylan
7.4 Allergan
7.4.1 Company profile
7.4.2 Representative Generic Drug Product
7.4.3 Generic Drug Sales, Revenue, Price and Gross Margin of Allergan
7.5 Hospira
7.5.1 Company profile
7.5.2 Representative Generic Drug Product
7.5.3 Generic Drug Sales, Revenue, Price and Gross Margin of Hospira
7.6 Dr. Reddy?s Lab.
7.6.1 Company profile
7.6.2 Representative Generic Drug Product
7.6.3 Generic Drug Sales, Revenue, Price and Gross Margin of Dr. Reddy?s Lab.
7.7 Stada
7.7.1 Company profile
7.7.2 Representative Generic Drug Product
7.7.3 Generic Drug Sales, Revenue, Price and Gross Margin of Stada
7.8 Greenstone
7.8.1 Company profile
7.8.2 Representative Generic Drug Product
7.8.3 Generic Drug Sales, Revenue, Price and Gross Margin of Greenstone
7.9 Par Pharma
7.9.1 Company profile
7.9.2 Representative Generic Drug Product
7.9.3 Generic Drug Sales, Revenue, Price and Gross Margin of Par Pharma
7.10 Sun Pharmaceutical
7.10.1 Company profile
7.10.2 Representative Generic Drug Product
7.10.3 Generic Drug Sales, Revenue, Price and Gross Margin of Sun Pharmaceutical
7.11 Aspen Pharmacare
7.11.1 Company profile
7.11.2 Representative Generic Drug Product
7.11.3 Generic Drug Sales, Revenue, Price and Gross Margin of Aspen Pharmacare
7.12 Fresenius
7.12.1 Company profile
7.12.2 Representative Generic Drug Product
7.12.3 Generic Drug Sales, Revenue, Price and Gross Margin of Fresenius
7.13 Lupin
7.13.1 Company profile
7.13.2 Representative Generic Drug Product
7.13.3 Generic Drug Sales, Revenue, Price and Gross Margin of Lupin
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF GENERIC DRUG
8.1 Industry Chain of Generic Drug
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF GENERIC DRUG
9.1 Cost Structure Analysis of Generic Drug
9.2 Raw Materials Cost Analysis of Generic Drug
9.3 Labor Cost Analysis of Generic Drug
9.4 Manufacturing Expenses Analysis of Generic Drug
CHAPTER 10 MARKETING STATUS ANALYSIS OF GENERIC DRUG
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
